James Schaub - 24 Jan 2023 Form 4 Insider Report for RVL Pharmaceuticals plc

Signature
/s/ Christopher Klein, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
24 Jan 2023
Net transactions value
-$12,106
Form type
4
Filing time
26 Jan 2023, 16:15:54 UTC
Previous filing
09 Aug 2022
Next filing
22 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Tax liability $12,106 -9,608 -1.8% $1.26 530,412 24 Jan 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.